ISP-6-3 The three-combined treatment, a novel HDAC inhibitor OBP801/YM753 and traditional cytotoxic drugs 5-FU/paclitaxel effectively induced apoptosis in human ovarian cancer SKOV-3 cells(Group 6 Oncology 6,IS Poster,International Session)

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本産科婦人科学会の論文
• 2014-02-01

著者

• Mori Taisuke

  Kyoto Prefectural University of Medicine

• Sawada Morio

  Kyoto Prefectural University of Medicine

• Kuroboshi Haruo

  Kyoto Prefectural University of Medicine

• Tatsumi Hiroshi

  Kyoto Prefectural University of Medicine

• Iwasaku Kazuhiro

  Kyoto Prefectural University of Medicine

• Matsushima Hiroshi

  Kyoto Prefectural University

• Kitawaki Jo

  Kyoto Prefectural University

• Yamamoto Takuro

  Kyoto Prefectural University

• Akiyama Makoto

  Kyoto Prefectural University

• Tatsumi Hiroshi

  Kyoto Prefectural University

関連論文

• ISP-20-1 Intravenous paclitaxel is specifically retained in human gynecologic carcinoma tissues in vivo(Group 20 Oncology 11,IS Poster,International Session)
• ISAC-4-3 Stimulation of Aromatase by Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha (PGC-1α) in Endometriosis(Group 4 Reproduction,IS Award Candidate,International Session)
• ISP-7-2 Estrogen related receptor-γ regulates proliferation and transcriptional activity of estrogen response cooperatively with estrogen receptor-α in uterine endometrial cancer(Group 7 Oncology 7,IS Poster,International Session)
• ISP-6-3 The three-combined treatment, a novel HDAC inhibitor OBP801/YM753 and traditional cytotoxic drugs 5-FU/paclitaxel effectively induced apoptosis in human ovarian cancer SKOV-3 cells(Group 6 Oncology 6,IS Poster,International Session)
• ISP-8-5 Intestinal-type adenocarcinoma possibly arising from a remnant of the rectovaginal fistula tract formed after intermediate-level imperforate anus repair(Group 8 Oncology 8,IS Poster,International Session)

スポンサーリンク